Form 4: Ginkgo Bioworks Holdings Insider Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Barry Canton, a 10% owner of Ginkgo Bioworks Holdings, Inc., reported multiple transactions in common stock on July 28, 2026.

Summary

  • Grant/award: acquired 35,736 Restricted Stock Units on July 28, 2026; holds 35,736 after (Direct).
  • Grant/award: acquired 117,135 Restricted Stock Units on July 28, 2026; holds 117,135 after (Direct).
  • Grant/award: acquired 39,038 Restricted Stock Units on July 28, 2026; holds 39,038 after (Indirect).
  • Grant/award: acquired 127,423 Restricted Stock Units on July 28, 2026; holds 127,423 after (Indirect).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Barry Canton — 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-07-28Grant/awardRestricted Stock Units35,736——35,736
2026-07-28Grant/awardRestricted Stock Units117,135——117,135
2026-07-28Grant/awardRestricted Stock Units39,038——39,038
2026-07-28Grant/awardRestricted Stock Units127,423——127,423

Key Dates

DateDescription
2026-07-28Grant/award (35,736 shares)
2026-07-28Grant/award (117,135 shares)
2026-07-28Grant/award (39,038 shares)
2026-07-28Grant/award (127,423 shares)

Keywords

insider transaction, Form 4, DNA, Ginkgo Bioworks Holdings, Inc., neutral, Barry Canton

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.